Posted by AGORACOM-JC
at 2:22 PM on Monday, January 6th, 2020
Patient Self-Monitoring Extends Physicians’ Reach for Proactive Monitoring of Atrial Fibrillation Recurrence and any Arrhythmia.
Confirms market traction with orders being placed by physician groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia monitoring
Dr. Yaariv Khaykin, Physician Lead at PACE and Chief Medical Information Officer at Southlake Regional Health Centre, stated, “We are very excited at the opportunity to introduce the use of this home-based ECG/arrhythmia monitoring technology to our patients empowering them to take greater charge of their health.”
TORONTO, ONTARIO / January 6, 2020 / CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, confirms market traction with orders being placed by physician groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia monitoring.
Partners in Advanced Cardiac Evaluation (“PACE“),
the largest arrhythmia practice in Ontario (Canada) placed a first order
of the HeartCheck™ CardiBeat Handheld ECG monitors and is recommending
its patients to use the devices for one year of in-home, self-monitoring
with an emphasis on detecting a recurrence of Atrial Fibrillation (“AF“)
following cardiac ablation treatment for AF. The Company confirms that
additional hospital affiliated physician groups have also purchased the
HeartCheck™ CardiBeat ECG devices for evaluation in their respective
practices with additional orders expected in early 2020.
AF is a life-threatening arrhythmia that is difficult to treat.
Cardiac ablation is a procedure commonly used to correct AF; however, AF
recurrence after ablation is common and can be “silent”, occuring
without any symptoms, discomfort or warning to the patient (See Note 1).
PACE patients will use the GEMS™ Mobile Smartphone app to record ECGs
taken by the HeartCheck™ CardiBeat which will then be automatically
forwarded by CardioComm’s SMART Monitoring ECG service directly into the
patient’s cardiologist’s Electronic Medical Record (“EMR”). Should any
submitted ECG recordings show a recurrence of AF or a presence of other
cardiac arrhythmias, the patients are contacted by PACE and follow-up
visits scheduled. ECG reports generated through GEMS™ Mobile are
eligible for medical service reimbursement in both Canada and the US.
Dr. Yaariv Khaykin, Physician Lead at PACE and Chief Medical
Information Officer at Southlake Regional Health Centre, stated, “We are
very excited at the opportunity to introduce the use of this home-based
ECG/arrhythmia monitoring technology to our patients empowering them to
take greater charge of their health.”
The GEMS™ Mobile app is available in Android and Apple Smartphone
compatible versions as a free downloadable app and allows users to
generate unlimited ECG reports to show to their physician. The app also
allows users to request their ECG to be reviewed by CardioComm’s SMART
Monitoring ECG reading service where the user does not have direct
connectivity to their treating physician.
To learn more about CardioComm’s products and for further updates
regarding HeartCheck™ ECG device integrations, please visit the
Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.
CardioComm Solutions’ patented and proprietary technology is used in
products for recording, viewing, analyzing and storing
electrocardiograms for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external
distribution network and a North American-based sales team. CardioComm
Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA
compliant and holds clearances from the European Union (CE Mark), the
USA (FDA) and Canada (Health Canada).
This release may contain certain forward-looking statements and
forward-looking information with respect to the financial condition,
results of operations and business of CardioComm Solutions and certain
of the plans and objectives of CardioComm Solutions with respect to
these items. Such statements and information reflect management’s
current beliefs and are based on information currently available to
management. By their nature, forward-looking statements and
forward-looking information involve risk and uncertainty because they
relate to events and depend on circumstances that will occur in the
future and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by
these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue
reliance on forward-looking statements and forward-looking information.
The Company does not assume any obligation to update the forward-looking
statements and forward-looking information contained in this release
other than as required by applicable laws, including without limitation,
Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Company collaborates with ZANA Technologies GmbH to integrate mobile ECG management and Smartphone App technologies
ECG technologies to be tested within ZANA’s remote patient monitoring platform in 2020
CardioComm’s GEMS™ ECG reviewing and HeartCheck™ ECG monitoring
technologies are being evaluated to support ZANA’s novel,
voice-directed, remote patient monitoring and patient management
platform.
Posted by AGORACOM-JC
at 2:13 PM on Monday, December 23rd, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
mHealth Market is Expected to Expand at a CAGR of 22.1% During 2017 to 2025
According to experts from TMR, the global mHelath market stood at US$23.9 bn in 2017
This revenue is expected to gain an impressive value of US$118.4bn by the end of 2025
Experts project this growth to occur with a meteoric CAGR of 22.1% during the forecast period from 2017 to 2025
The globalmHelath market bears
a highly fragmented vendor landscape, says Transparency Market Research
(TMR) in a recently published report. This is solely because of the
existence of large, medium, and small-scale players in the market. Withings, FitBit, Apple Inc., Jawbone, and Dexcom are the dominant players working in the global mHelath market.
Out of the various strategic alliances
adopted by players in the global mHelath market to hold a sizeable
stakes, capitalizing on the emerging opportunities and acquiring latest
technologies and tools has gained maximum popularity. The level of
competition among leading vendors is getting escalated with rising use
of technologies and smart devices such as wearables. The global mHelath
market is expected to grow steadily due to the presence of highly
established players who are concentrating on improving their product
quality, facilitating product differentiation, and enhancing
geographical reach. These companies are also attempting to introduce
advanced and new products into the industry on a daily basis.
According to experts from TMR, the
global mHelath market stood at US$23.9 bn in 2017. This revenue is
expected to gain an impressive value of US$118.4bn by the end of 2025.
Experts project this growth to occur with a meteoric CAGR of 22.1%
during the forecast period from 2017 to 2025.
Among various products in the global
mHelath market, connected medical devices hold substantial share, which
is expected to boost the global mHelath market during the forecast
period. This is because of rising focus towards fitness and increasing
use of heart rate monitors among people. Region wise, North America is
expected to lead the global mHelath market in the coming years. This is
attributed to a strong technological infrastructure along with high
healthcare expenditure in the region.
Integration of Wireless Technologies to Fuel mHealth Market’s Growth
Health-related technologies and mobile
applications are often known as mHealth, which helps in managing
patients’ experiences. Such health mobile technologies and apps utilize
advanced data analytics to help medical professionals in providing their
patients best care at low cost. These health mobile applications
facilitate easy and better health management through simple apps such as
diet, exercise trackers, and calorie-counting. Such USPs are driving
the global mHelath market. Along with this, rising penetration of
internet connections and smartphones, and rapid technological
advancements in healthcare industry are the factors majorly fueling
growth in the global mHelath market.
Furthermore, mHelath ensures continuous
communication between medical professionals and patients, thereby allow
physicians to monitor, and diagnose patients without seeing them in
person. Such benefits are also boosting the global mHelath market. Apart
from these, rapid adoption of connected devices for monitoring various
chronic diseases, and increasing demand for cost-effective medical
services are also propelling expansion in the global mHelath market.
Low Physician Density May Hinder mHealth Market’s Growth
Growing reluctance of physicians to move
over conventional methods, lack of regulations, concerns about data
security, and low density of skilled professionals are some of the major
challenges in the global mHealth market. Nonetheless, persistent demand
and rising prevalence of various lifestyle disorders is believed to
help industry players overcome these challenges in the near future.
About Us
Transparency Market Research is a
next-generation market intelligence provider, offering fact-based
solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions
for businesses to grow, evolve, and mature. Our real-time data
collection methods along with ability to track more than one million
high growth niche products are aligned with your aims. The detailed and
proprietary statistical models used by our analysts offer insights for
making right decision in the shortest span of time. For organizations
that require specific but comprehensive information we offer customized
solutions through adhoc reports. These requests are delivered with the
perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions
for clients-specific problems with right methodology of research is the
key to help enterprises reach right decision.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on #Mhealth Market is Expected to Expand at a CAGR of 22.1% – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 3:52 PM on Thursday, December 19th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
What’s App? – End of Year Round-up on mHealth App Developments
Advantages of mHealth apps include streamlining the exchange of health information and a better user experience
From a data perspective, apps can use big data to analyse unstructured data and identify patterns and environmental factors that will improve patient treatment
An Irish Times special report estimates that over seven million
patients worldwide are actively using digital health apps as part of
their care plan. The availability of remote and mobile healthcare
solutions relating to fitness, wellbeing, health and medical treatment
could be life-changing for those living in countries lacking easy access
to medical care.
Advantages of mHealth apps include streamlining the exchange of
health information and a better user experience. From a data
perspective, apps can use big data to analyse unstructured data and
identify patterns and environmental factors that will improve patient
treatment.
Government adoption
With this in mind, many governments are encouraging the uptake of mHealth apps.
In the UK, the NHS website has a digital library showcasing mHealth
apps. It lists mHealth apps that have been deemed as clinically safe.
The functionality of the apps is varied and provides services like
repeat prescriptions services, speech and language therapy, and instant
access to medical records. Patients can even use certain apps to monitor
their conditions such as diabetes.
The HSE in Ireland is following the lead of the NHS. It is working
with Orcha, a company that reviews health apps, to provide an Irish
eHealth app library that lists apps reviewed by Orcha.
Orcha assesses mHealth apps’ data use policies and compliance with
relevant standards. It rates the app out of a maximum score of 100, with
a lower score indicating that there may be issues that the user should
investigate before using the app. Clinical assurance and user experience
are also rated to help users and clinicians compare mHealth apps.
The Irish eHealth app library to date lists over 700 mHealth apps.
The HSE points out that the library is a tool for users to identify and
compare apps themselves but it is not intended to promote or recommend
any particular app.
Other developments
Other recent developments in the mHealth sector include:
A WhatsApp style messaging app developed by junior doctors that the
developers claim could save the NHS £44m a year. The app helps NHS
workers exchange patient information, make clinical decisions, manages
their workload in a legally compliant forum and removes the need for
pagers. Currently more than 100 NHS hospitals and care commissioning
groups in the UK are using the app.
An app that monitors children’s temperature. It uses a patch to
wirelessly monitor the baby’s temperature and sends alerts to
smartphones. Unlike a typical thermometer, children do not have to be
woken from their sleep to obtain temperature readings.
Tablets with micro ingestible sensors embedded in the pills that can
alert smartphones when the pills touch the stomach lining of patients.
The developers believe this could be useful for the treatment of mental
illnesses if medication compliance is proving difficult. It could also
be an invaluable tool for pharmaceutical companies or medical
institutions to record timings of ingestion of medications during
clinical trials.
A device and accompanying app that takes ECG recordings via
electrodes. The AI system of the software performs an automatic analysis
and informs the patient of their heart rhythm. This data can then be
sent directly to the patient’s clinician for further analysis and
consultation. The product has already launched in the UK.
A skin mapping app that incorporates AI technology. The app is
designed to detect new moles or marks on the skin. These are one of the
most common warning signs of melanoma and early detection can improve
the success rate of treatment.
Adia Health provides at-home finger prick fertility blood tests, a
preconception plan to help improve fertility health and access to
fertility specialists remotely.
At a broader level, technologies like blockchain, the Internet of
Things and AI / augmented reality are taking mHealth to the next level.
Despite this, the technological advancement and wider adoption of
mHealth apps brings important legal responsibilities. From a medical
standpoint, mHealth apps can be very useful, but they can never replace
the advice of someone’s own clinician.
Regulatory considerations
Depending on their functionality, some mobile apps and standalone
software may fall within the definition of a ‘software medical device’.
Any mHealth app deemed to be a software medical device will be subject
to onerous obligations regarding safety, compliance and post market
surveillance.
Earlier this year, the British Medical Journal warned that popular
mHealth apps may not be keeping personal data about medical conditions
confidential and users may not be aware of how the data they provide on
these apps is being shared.
In Ireland, mHealth apps must comply with laws like the General Data
Protection Regulation (GDPR) and the Irish Data Protection Acts 1988 –
2018. The Data Protection Acts transpose into Irish law the EU’s Law
Enforcement Directive and adopt specific rules to regulate the
processing of personal data for the purposes of health research.
At a basic level, mHealth apps that process personal data revealing
information about an individual’s health will attract more stringent
data protection obligations as this data is ‘special category data’
under data protection law. Processing any special category data is only
allowed in the limited circumstances set out in Article 9 of the GDPR.
As the vast majority of mHealth apps are designed to operate online
they are vulnerable to cyber-security threats. The GDPR make it
essential for a data controller to adopt robust security practices for
personal data, which may include pseudonymising or encrypting it.
Code of Conduct on privacy for mHealth apps
The Code of Conduct on privacy for mHealth apps aims to regulate and
secure the personal data gathered by mHealth apps and promote trust
among users. The Code has not yet been approved and the European
Commission is working with industry stakeholders to encourage the
further development of the current draft Code.
What the future holds
There have been many new developments in 2019 in the mHealth app
sector. It is reassuring that governments are encouraging more
widespread adoption of digital healthcare solutions by healthcare
practitioners and individuals. However, if mHealth apps are to truly
flourish, individuals must trust the mHealth industry and how it is
regulated.
Many mHealth apps have access to vast amounts of sensitive health
information. There are important data protection implications if special
category data relating to individual’s health is collected and
processed. Given the increased privacy and security risks, tech
companies and app developers must be aware of the data protection laws
and ensure they are complying with them. From a transparency
perspective, they should also ensure users are aware of how the data
they provide on mHealth apps is being shared.
From a regulatory point of view, it would be prudent for tech
companies and app developers to determine if an app is a software
medical device. If so, they should ensure they are meeting their
obligations regarding safety, compliance and post market surveillance
and keep up to date with regulatory changes due to take effect next
year.
We also hope 2020 brings progress in finalising the draft Code of
Conduct on privacy for mHealth apps that will set out practical guidance
for app developers on data protection principles when developing
mHealth apps.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca – What’s App? – End of Year Round-up on #Mhealth App Developments $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 1:39 PM on Wednesday, December 18th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Remote Patient Monitoring, Reimbursement Topped Headlines in 2019
Top mHealth trends in 2019 included remote patient monitoring,
telehealth reimbursement, substance use disorder care, chronic disease
management, and direct-to-consumer mHealth technology.
Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.
As 2019 comes to an end, healthcare organizations are
reflecting on the trends and stories that most influenced their
behaviors in the past year. Based on our most clicked stories in 2019,
those trends included remote patient monitoring, telehealth
reimbursement and coding, behavioral health/substance use disorder care,
chronic disease management strategies, and direct-to-consumer mHealth
technologies.
In the following article, mHealthIntelligence.com will break down these trends, as well as the strategies and best practices industry leaders developed in response.
Remote patient monitoring
In 2019, healthcare organizations looked to invest in remote
patient monitoring (RPM) solutions to transition to value-based care.
Many healthcare leaders expected these solutions to support high-risk
chronically ill patients whose conditions are considered unstable and at
a risk for hospital admission.
Specifically, 88 percent of providers who were surveyed by health IT thought leaders earlier this year had invested or were evaluating investments in RPM technologies.
RPM solutions have been proven to be clinically effective as an
early symptom management tool for chronically ill patients, who
represented about 45 percent of the US population according to the
survey. These solutions allowed risk-bearing organizations to remotely
monitor patients with chronic conditions to help control healthcare
costs, improve care quality, and increase access to care for patients in
underserved areas.
In addition, these solutions helped manage value-based risk associated with large patient populations with chronic conditions.
“The ability of the device to simultaneously record multiple
variables such as heart rate and accelerometer data allowed us to more
accurately determine the patient’s state, whether he/ she is active,
sedentary, asleep, or not currently using the device,†the researchers
reported.
Because remote patient monitoring is becoming more widespread,
more healthcare organizations are implementing RPM into their health
systems. Recently, Humana announced
a partnership with Philips Health to launch a remote member monitoring
pilot for certain Medicare Advantage members with severe congestive
heart failure (CHF).
“Our goal is to continue to find ways to help our Medicare
Advantage members stay longer and safer in their homes,†Susan Diamond,
president of Humana’s Home Business segment, said in a press release.
Telehealth reimbursement and coding
Along with remote patient monitoring, telehealth has been
extremely vital for healthcare in 2018 and will continue to play a
significant role going into the new year. But healthcare organizations
are still waiting on reimbursement and billing policies to catch up to
telehealth adoption..
One of the top read stories from 2019 was the American Medical
Association’s (AMA) creation of new codes for the use of telehealth and
behavior assessment and intervention services. These codes “more
accurately reflect current clinical practice that increasingly
emphasizes interdisciplinary care coordination and teamwork with
physicians in a primary care and specialty setting,†the association
stressed.
The goal for the new codes was to expand pathways for
physicians across the US who deal with diverse patients, including those
from underserved areas, and those who have any access to care they may
need.
CMS has followed suit, implementing the
AMA and its Digital Medicine Payment Advisory Group to include new
telehealth codes in the 2018 Medicare physician fee schedule. And in the
beginning of this year, CMS released its 2020 physician fee schedule
that included numerous additions that will enable more reimbursement for
connected health services next year.
In October of this year, Pennsylvania tried again to pass comprehensive telehealth legislation after the bill was denied last year because of disagreements over payment parity.
State Senator Elder Vogel introduced The Telemedicine Act (SB
857), which aimed to establish definitions for telemedicine and
telehealth, provide temporary evaluation and treatment guidelines for
reimbursement, and give state departments up to two years to draft
permanent rules and regulations.
The new bill includes remote patient monitoring technologies,
which gives providers the opportunity to use these connected health
services. About a dozen states have passed legislation demanding payment
parity for telehealth, but most have failed because of strong
opposition from healthcare payers.
Addressing substance abuse using mHealth
An estimated
115 people die each day from opioid abuse, an issue that has become
more widespread in the past decade. Healthcare providers have been
actively searching for a solution to tackle this issue, and many have
found a pathway to success using mHealth and telehealth technology.
Applying MHealth and telehealth technology to addiction treatment is expected
to make one of the biggest impacts on substance use disorder care.
Connected health platforms allow providers to work with the individual
patient anytime they need to, and are able to see what the patient
experiences each day.
“We’re building a panoramic view of your life,†said Jacob
Levenson, CEO of MAP Health Management, a Texas-based national network
of almost 100 addiction treatment providers. The organization has
adopted digital health tools for care management and coordination of
substance use disorder patients.
The smartphone is also a great tool for addiction treatment, as it offers both
a platform for population health programs and individual treatments.
Healthcare providers are able to send out messages offering support or
information via text, SMS, or e-mail to large groups at any time. They
can also personalize messages for individuals, connecting information to
one’s habits, location, or medical record.
MHealth apps are becoming increasingly more popular tools. Apps
could feature surveys, messaging or chat rooms, links to resources,
messaging with care providers or a substance abuse specialist, and a 911
link for immediate help.
“Medical devices, including digital health devices like mobile
medical apps, have the potential to play a unique and important role in
tackling the opioid crisis,†FDA Commissioner Scott Gottlieb, MD, said
in a press release
featured on the FDA website. “We must advance new ways to find tools to
help address the human and financial toll of opioid addiction.â€
Chronic disease management strategies
While MHealth platforms were important for addressing the
opioid crisis, the solutions have also been useful for chronic disease
management. A growing number of Americans are suffering from more than
one chronic condition, prompting more healthcare providers to take the
appropriate measures to tackle this issue in 2019.
For example, in January, Omada Health, a digital therapeutics
company that focuses on obesity-related chronic conditions, created a
cognitive behavioral therapy program (CBT) for those dealing with
depression and anxiety.
“Depression and anxiety are a known barrier to healthy
behaviors including medication adherence, optimal nutrition, and seeking
timely preventive care. With the addition of CBT curriculum, we can
more fully support our participants as they manage their conditions.
And, through our digital platform, we can do it at scale,†Carolyn
Bradner Jasik, MD, Omada’s Vice President of Medical Affairs, explained
in a press release.
The challenge going into the coming years is developing a
digital health platform that is able to integrate different programs and
allow for easy access for both patients and providers.
A few weeks ago, a Pennsylvania health system also created a telehealth and remote patient monitoring platform
to allow patients living with ALS to receive at home care. Most
patients with ALS have to travel hours for meetings with doctors and
specialists, which can prove to be challenging. But the telehealth
platform allows the meetings to be held at home.
Heart failure (HF) patients receiving targeted virtual behavior
therapy found significant improvements in self-care, a recent study published in
the journal Circulation found. The study conducted by Humana and AbleTo
found a correlation between improving behavioral health care and
co-existing physical conditions. The study also noted improvements in
self-care, depression symptoms, and awareness of physician
recommendations among patients that received HF-focused virtual
behavioral therapy over eight weeks.
Chronic disease management is vital to reduce costs by
addressing the patient’s illness or condition with maximum clinical
outcomes, while helping beneficiaries control their disease in an
effective way.
Direct-to-consumer mHealth technology
The healthcare industry is facing major disruption from
non-traditional companies, like Amazon, Google, and Apple. The mHealth
space has been no different according to the top stories from 2019.
In September of this year, Amazon prepared to take on the direct-to-consumer telehealth industry through its new platform,
Amazon Care. Amazon Care is a virtual care clinic offering telehealth
and mHealth services for its employees in the Seattle area, including
on-demand access to a clinician online messaging for healthcare
questions, a prescription service, and the option of scheduling an
appointment through Seattle-based Oasis Medical.
Apple Watch can be used by clinicians to detect atrial
fibrillation. But will care providers rely on these devices to present
them with accurate information?
A survey of
420,000 individuals conducted by researchers at the Stanford University
School of Medicine found that over an eight month span, the Apple Watch
detected an irregular heart rate in .52 percent of individuals or 2,161
people. And almost three-quarters of the users who were notified about
an irregular pulse contacted a care provider for further treatment.
“The study’s findings will help patients and clinicians
understand how devices like Apple Watch can play a role in identifying
atrial fibrillation, a deadly and often undiagnosed disease,†Mintu
Turakhia, MD, an associate professor of cardiovascular medicine, said in
the press release.
“Additionally, these important findings lay the foundation for further
research into the use of emerging wearable technologies in clinical
practice and demonstrate the unique potential of large-scale app-based
studies.â€
In addition, a Gallup survey this month showed that nearly one
in five Americans are using an mHealth wearable. Adults younger than 55
are twice as likely to use or have used mHealth. And individuals older
than 55 and women, are more interested in using mHealth than men. About
half of the women respondents under 55 said they use or have used
mHealth in the past. While men over age 55 are the least likely to use
or have used the technology.
Jefferson Health recently partnered
with Quick’r Care to create a mHealth platform to allow patients to
choose their correct care path. Through JeffConnect’s virtual care
service. Consumers will have on-demand video access to health system’s
care providers.
“This is what people who feel bad need right now, right when
they begin to feel sick,†added Stephen K. Klasko, MD, president of
Thomas Jefferson University and CEO of Jefferson Health. “Working with
Quick’rCare allows us to expand our commitment to healthcare with no
address.â€
Overall, Apple products are designed to make healthcare more
human. Devices are meant to protect patient data and give easy
accessibility to everyone who uses Apple products. Patients are able to
access medical records and communicate from at home if needed. But
providers continue to question whether the information they are
receiving is accurate, as with new technologies, there isn’t always this
guarantee.
Posted by AGORACOM-JC
at 11:59 AM on Tuesday, December 17th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Mobile Health (MHealth) Technologies Market Projected to Gain Significant Value
The global mHealth market should reach $46.2 billion by 2021 from $13.2 billion in 2016 at a compound annual growth rate (CAGR) of 28.6%, from 2016 to 2021.
Report Scope:
This new report on mobile health will provide a brief description of
the current status of the industry and recent developments. It presents
the changing environment, in terms of new challenges and opportunities
for app development, remote monitoring and networking medical data. The
report analyzes the market trends, leading service providers,
therapeutic markets and the most popular mHealth applications, in terms
of downloads and revenues.
Report Includes:
– A global overview of the mobile health technology market. –
Analyses of global market trends, with data from 2014 and 2015,
estimates for 2016, and projections of compound annual growth rates
(CAGRs) through 2021. – A presentation of the changing mobile health technology environment in terms of new challenges and rising opportunities. – Information regarding market trends, leading service providers, therapy markets, and the most popular mHealth applications.
– Insight into the second generation of mHealth devices, projected
regulatory patterns, and innovative devices and services to be launched
in the near future. – Company profiles of major players in the industries covered.
Report Summary
Mobile health (mHealth) is the use of mobile and wireless
technologies to support healthcare systems and achieve healthcare
objectives. Digital health solutions have the potential to improve the
quality of healthcare, to democratize medical knowledge and provide
healthcare to billions or people who have limited or no access to
services. The provision of healthcare remains high on the economic and
political agenda and continues to demand a huge share of gross domestic
product (GDP) in industrialized countries, where an aging population and
increase in the prevalence of chronic noncommunicable diseases (NCDs)
remains a challenge.
mHealth can provide better and more consistence solutions within the
global healthcare environment and will change the way services are
provided in the future. Smart devices and wearable are empowering
individuals to more effectively manage their care, raising awareness,
providing continuous monitoring and disseminating of information to the
patient and healthcare professionals; driving a more proactive,
patient-centric healthcare system.
Posted by AGORACOM-JC
at 2:29 PM on Monday, December 16th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Digital Health Market Latest Innovations and Industry Analysis
Rapid Adoption of mHealth Technologies Drives the Market
“Rising number of government initiatives aimed at promoting digital health solutions will enable growth in the market,â€
The Global Digital Health Market is driven by several factors. “Rising number of government initiatives aimed at promoting digital health solutions will enable growth in the market,†said a lead analyst at Fortune Business insights. “In the coming years the digital health market is estimated to benefit from the uptake of IT in the medical industry,†he added. With the increasing use of smartphones across the world the demand for digital health services is growing owing to the rising adoption of mhealth apps.
Other factors such as the rising demand for in-house remote
monitoring devices and increasing geriatric population will catalyze
growth of the digital health and wellness services. Digital health over
the past few years has become a game changer in the digital health
industry. Digital health services help in monitoring diseases and
provide access to electronic information of patients through tablets or
mobiles. Doctors can check the complete digital health record of their
patients and accordingly offer the best consultation. All the factors
mentioned above are anticipated to boost the digital health market
during the forecast period.
Posted by AGORACOM-JC
at 3:20 PM on Thursday, December 5th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
mHealth Device Market Rise +35.03% of CAGR By Upcoming Developments + Future Investment
mHealth Device Market is Witnessing Rising Acceptance of Connected Technology Solutions
Mobile health is one of the most disruptive trends ever occurred in the healthcare sector.
mHealth refers to mobile health, one of the most disruptive trends
ever occurred in the healthcare sector. It is a public health practice
supported by mobile devices, commonly used for health services,
information, and data collection through mobile communication devices,
such as mobile phones, computers, tablets or PDAs, and wearable devices
like smartwatches. mHealth is also defined as a sub-segment of eHealth,
which uses ICT (information & communication technology), such as
communications satellites, patient monitors, etc.
The global mHealth device market share is expected to create a valuation of over USD 48,663.2 MN by 2023. In its mHealth market growth analysis, MRFR also asserts that the market would register a massive 35.03% CAGR throughout the forecast period (2017 – 2023).
Research Synopsis
MHealth devices include mobile devices, real-time monitors for vital
signs, and telemedicine. mHealth solutions allow users to access the
collected data to check and maintain the health-related activities,
using technologies such as Bluetooth, mobile network (GSM/GPRS/3G/4G),
and Wi-Fi. Such advantages are encouraging the acceptance of mHealth
devices in growing numbers of healthcare facilities, which increases the
size of the mHealth solutions market globally.
The rapid adoption of portable and smart devices such as tablets and
smartphones is a key driving force for the growth of the connected
healthcare device market services.Besides, advancements in connectivity
and mHealth technology solutions act as a major tailwind for the market
growth. Simultaneously, factors such as rising patient involvement n
personal healthcare and the introduction of connected healthcare
solutions are impacting the growth of the market positively. An increase
in lifestyle disease and benefits of mHealth solutions such as
cost-effectiveness & convenience foster market growth. Furthermore,
raising awareness among patients is driving market growth.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca – #Mhealth Device Market to Rise 35% Due to Upcoming Developments + Future Investment $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 3:09 PM on Wednesday, December 4th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
How mHealth apps are providing solutions to the healthcare market’s problems
Mobile health is the monitoring and sharing of health information via mobile technology – such as wearables and health tracking apps.
The use of mobile devices and wireless technology to monitor symptoms and deliver care allows physicians to make diagnoses quicker and with fewer errors.Â
Today’s consumers don’t want to solely rely on yearly physicals or
scattered drop-in appointments to monitor their health – they are
seeking more individualized control over the way healthcare is accessed
so that they can analyze personal health data and talk to healthcare
professionals at all times.
By embracing mobile health, or mHealth, patients are able to keep
track of their own health data in real time and inform healthcare
providers of any abnormalities at the push of a button.
What is mHealth (mobile health)?
Mobile health is the monitoring and sharing of health information via mobile technology – such as wearables
and health tracking apps. The use of mobile devices and wireless
technology to monitor symptoms and deliver care allows physicians to
make diagnoses quicker and with fewer errors.
And as tech giants like Apple and Google continue pushing their way into healthcare, mHealth will likely grow in popularity.
mHealth vs telehealth
Telehealth
uses technology to extend the reach of healthcare professionals beyond
traditional clinical settings. It’s a broad term describing how the
healthcare market is taking advantage of digital development to enable
remote care.
Comparatively, mHealth is a subset of telehealth, referring
specifically to the use of mobile technology to inform and educate
consumers on healthcare. It uses mobile devices to monitor patients’
exercise, heart rate, and medication adherence.
Examples of different types of mHealth apps
Mobile health is gaining steam among consumers as Apple and Google
continue to offer an array of mHealth applications on their app stores;
there were more than 318,000 mHealth apps available for download
worldwide as of November 2017. Some of the most common categories of
mHealth apps include:
Diabetes
Pregnancy
Weight loss
Chronic illness
Benefits of mHealth app solutions
Stakeholders across the healthcare industry are looking to tap into
the mHealth opportunity as Mobile health applications are beginning to
integrate electronic health records (EHRs) and other wearable tech devices.
According to Business Insider Intelligence, nearly half of all
mHealth app publishers integrate with EHRs in order to provide a
detailed representation of a patient’s health or medical history.
Stakeholders across the healthcare industry are looking to tap into the mHealth opportunity.
Business Insider Intelligence
Healthcare providers could reduce appointment costs by taking
advantage of mHealth applications – which lowers the risk of patient
rehabilitation. Instead of staying in a healthcare facility post
surgical discharge, patients could utilize mHealth apps for recovery
instructions and medication reminders.
Payers – which handle the financial aspects of healthcare – can also
capitalize on mHealth cost benefits. According to a 2018 Leavitt
Partners report, clinical care only accounts for 20% of health, and
social determinants account for the remainder.
Health insurance providers could develop mobile apps that provide
consumers with health education and send reminders to purchase healthy
food – keeping patients largely responsible for their own healthcare.
mHealth industry trends & technologies
One concern consumers have regarding mHealth solutions has to do with
data-sharing practices among multiple technologies and applications.
According to Business Insider Intelligence, 79% of 24 top-rated mHealth
apps shared user data with 55 entities, like app developers and third
parties.
Despite privacy concerns however, Business Insider Intelligence
predicts that as big tech companies like Apple and Samsung continue to
generate their own health features in smartphones, the adoption of
mHealth apps will continue to grow.
In fact, Apple grew wearable revenue 42% year-over-year in 2018 and has the potential to hit $15 billion in healthcare-related revenue by 2021.
Business Insider Intelligence’s Digital Health Ecosystem Report
explores digital disruption in healthcare, detailing how technologies
like mobile health apps are reshaping the industry. The report outlines
the role of major players in healthcare from payers to consumers –
explaining how they’re all being affected amid the industry’s digital
awakening.
Posted by AGORACOM-JC
at 8:55 AM on Tuesday, December 3rd, 2019
Karlsruhe, Germany-based start-up ZANA Technologies GmbH entering into a business collaboration where CardioComm
ECG technologies to be tested within ZANA’s remote patient monitoring platform in 2020
Toronto, Ontario–(December 3, 2019) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company” or “CCS“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) acquisition and management software solutions, and Karlsruhe, Germany-based start-up ZANA Technologies GmbH (“ZANA“) confirm entering into a business collaboration where CardioComm’s GEMS™ ECG reviewing and HeartCheck™ ECG monitoring technologies are being evaluated to support ZANA’s novel, voice-directed, remote patient monitoring and patient management platform.
Through the use of deployable versions of the GEMS™ Mobile
Smartphone, the GUAVA ECG viewer and GEMS™ ECG management software, ZANA
will embed CardioComm’s ECG management technologies into its mobile app
and patient engagement platform. ZANA users will be able to download
one Smartphone app through which ECG recordings and clinical feedback
will be provided using ZANA’s cloud-based patient engagement platform
where CardioComm’s hospital ECG management software technologies will
have been incorporated.
ZANA has decided to partner with CardioComm Solutions and its
HeartCheck™ CardiBeat ECG device and GEMSTM software solutions to be
evaluated by multiple medical centres throughout Europe in ZANA’s bid to
become a preferred vendor for telemedicine solutions for monitoing a
patient’s post-hospital discharge. ZANA’s disruptive patient enagement
platform uses an intelligent, voice-/chat-based assistant with
interactive and learning technologies that permit home-based, continuous
health monitoring, designed to improve the health outcomes of its
patients. As patient ECG monitoring requirements evolve, CardioComm will
provide ZANA support in expanding the user’s access to other ECG
monitoring methodologies that may be requested as part of any
comprehensive physician-directed hospital discharge plan. This will
include the use of 12 lead ECGs and long-term continuous ECG monitoring
devices.
The companies will provide updates on the clinical testing results as
they become available. To learn more about CardioComm’s products and
for further updates regarding HeartCheck™ ECG device integrations,
please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.
About CardioComm Solutions
CardioComm Solutions’ patented and proprietary technology is used in
products for recording, viewing, analyzing and storing
electrocardiograms for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external
distribution network and a North American-based sales team. CardioComm
Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA
compliant and holds clearances from the European Union (CE Mark), the
USA (FDA) and Canada (Health Canada).
About ZANA
Zana Technologies GmbH is an award-winning digital health start-up
based in Germany that offers cutting-edge conversational AI and
wearables integration for remote health monitoring. The main product
offering is an intelligent voice assistant that establishes a direct
bridge between patients and doctors. The innovative remote care solution
is designed to improve and lower costs of post-operative and chronic
care. ZANA combines active conversation in natural language with
real-time monitoring through connected devices, all from the comfort of a
patient’s home through a Smartphone or smart home device. ZANA’s
backend collects and presents the monitored patient’s data through an
innovative dashboard system that updates doctors about their patient’s
health continuously and securely.
This release may contain certain forward-looking statements and
forward-looking information with respect to the financial condition,
results of operations and business of CardioComm Solutions and certain
of the plans and objectives of CardioComm Solutions with respect to
these items. Such statements and information reflect management’s
current beliefs and are based on information currently available to
management. By their nature, forward-looking statements and
forward-looking information involve risk and uncertainty because they
relate to events and depend on circumstances that will occur in the
future and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by
these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue
reliance on forward-looking statements and forward-looking information.
The Company does not assume any obligation to update the forward-looking
statements and forward-looking information contained in this release
other than as required by applicable laws, including without limitation,
Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm $EKG.ca Collaborates with ZANA Technologies GmbH to Integrate Mobile #ECG Management and Smartphone App Technologies #Mhealth $TLT.ca $OGI.ca $ACST.ca $IPA.ca
